Education
About Us
Working with TipRanks
Follow Us
Panacea Biotec Limited (IN:PANACEABIO)
:PANACEABIO
RESEARCH TOOLSreports
PANACEABIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹220.95 - ₹581.00
Previous CloseN/A
Volume134.82K
Average Volume (3M)13.44K
Market Cap
₹24.19B
Enterprise Value₹16.83B
Total Cash (Recent Filing)₹1.77B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)210.9
Beta1.71
Next Earnings
Nov 12, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 19, 2011Dividend YieldN/A
Share Statistics
EPS (TTM)0.66
Shares Outstanding61,250,744
10 Day Avg. Volume6,869
30 Day Avg. Volume13,444
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹398.00Price Target Upside2.16% Upside
Rating ConsensusHold
Number of Analyst Covering0
Panacea Biotec Limited News
PANACEABIO FAQ
What was Panacea Biotec Limited’s price range in the past 12 months?
Panacea Biotec Limited lowest stock price was ₹220.95 and its highest was ₹581.00 in the past 12 months.
What is Panacea Biotec Limited’s market cap?
Panacea Biotec Limited’s market cap is ₹24.19B.
When is Panacea Biotec Limited’s upcoming earnings report date?
Panacea Biotec Limited’s upcoming earnings report date is Nov 12, 2025 which is in 75 days.
How were Panacea Biotec Limited’s earnings last quarter?
Panacea Biotec Limited released its earnings results on Aug 14, 2025. The company reported ₹0.661 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.661.
Is Panacea Biotec Limited overvalued?
According to Wall Street analysts Panacea Biotec Limited’s price is currently Undervalued.
Does Panacea Biotec Limited pay dividends?
Panacea Biotec Limited pays a Annually dividend of ₹0.75 which represents an annual dividend yield of N/A. See more information on Panacea Biotec Limited dividends here
What is Panacea Biotec Limited’s EPS estimate?
Panacea Biotec Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Panacea Biotec Limited have?
Panacea Biotec Limited has 61,250,744 shares outstanding.
What happened to Panacea Biotec Limited’s price movement after its last earnings report?
Panacea Biotec Limited reported an EPS of ₹0.661 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.276%.
Which hedge fund is a major shareholder of Panacea Biotec Limited?
Currently, no hedge funds are holding shares in IN:PANACEABIO
Company Description
Panacea Biotec Limited
Panacea Biotec Limited (PANACEABIO) is a leading biotechnology and pharmaceutical company based in India, focusing on the development, manufacturing, and marketing of vaccines, pharmaceuticals, and biosimilars. The company's core products include vaccines for infectious diseases, immunosuppressants, and critical care medicines, catering to both domestic and international markets.
Technical Analysis
Alkem Laboratories Ltd.
―
Aurobindo Pharma Ltd
―
GlaxoSmithKline Pharmaceuticals Limited
―
Glenmark Pharmaceuticals Limited
―
IPCA Laboratories Limited
―